"Welcome to Bobby Buka M.D., a neighborhood practice with a national reputation in medical and cosmetic dermatology. Founded by leading Manhattan dermatologist Robert Buka, M.D., our office provides quality skin care focusing on health and ageless beauty for all ages and all skin types. From Medical treatments to laser and cosmetic therapies, we offer the quality and concerned care patients should expect. Our signature treatments, like the Ten-Minute Facelift and Acne Boot Camp, combine state-of-the-art technology and the best cosmetic dermatology for results that are fresh and satisfying. Our office boasts a friendly, knowledgeable staff and comfortable surroundings to make you feel at ease."

During the past decade, Greenwich Village Dermatology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Greenwich Village Dermatology" #1 sponsor was "Incyte Corporation" with 4 trials, followed by "Arena Pharmaceuticals" with 1 trials sponsored, "Elorac, Inc." with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "LEO Pharma" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Greenwich Village Dermatology" are "Atopic Dermatitis" (4 trials), "Hidradenitis Suppurativa" (2 trials), "Vitiligo" (2 trials), "Alopecia Areata" (1 trials) and "Chronic Spontaneous Urticaria" (1 trials). Many other conditions were trialed in "Greenwich Village Dermatology" in a lesser frequency.

Most popular intervention types in "Greenwich Village Dermatology" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Ruxolitinib cream" (2 trials), "Vehicle" (2 trials), "Etrasimod 1 mg" (1 trials), "Etrasimod 2 mg" (1 trials) and "Etrasimod matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Greenwich Village Dermatology" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Greenwich Village Dermatology". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Greenwich Village Dermatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Greenwich Village Dermatology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".